| Followers | 24 |
| Posts | 1507 |
| Boards Moderated | 0 |
| Alias Born | 04/05/2016 |
Monday, September 06, 2021 9:17:34 PM
NP man. My buddy and I talk on the phone last week 10-14hrs total about this ticker.
He is a very accredited investor and has a lot of $ on this play.
Going over the different convertible notes, SS, amongst other things.
We both came to the conclusion based off our long conversations that the restricted shares could and hell, may already have been used to pay off convertible debt.
Bc both him and I were concerned about convertibles.
That would kill this ticker or severely damage it upon any good news
So
Restricted = more than enough COH to pay convertible debt.
They still have 7M on top of that, but its not convertible so in a buyout who cares
Furthermore, I hope in the next 8k Koos announces a significant reduction or elimination of convertible debt.
He is a very accredited investor and has a lot of $ on this play.
Going over the different convertible notes, SS, amongst other things.
We both came to the conclusion based off our long conversations that the restricted shares could and hell, may already have been used to pay off convertible debt.
Bc both him and I were concerned about convertibles.
That would kill this ticker or severely damage it upon any good news
So
Restricted = more than enough COH to pay convertible debt.
They still have 7M on top of that, but its not convertible so in a buyout who cares
Furthermore, I hope in the next 8k Koos announces a significant reduction or elimination of convertible debt.
Recent RGBP News
- Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 • GlobeNewswire Inc. • 09/23/2025 12:00:00 PM
- Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate • GlobeNewswire Inc. • 09/16/2025 12:00:00 PM
